HK Stock Market Move | AK MEDICAL(01789) surges more than 8% again, orthopedic surgery Siasun Robot&Automation's sales revenue growth rate exceeds 200%
Amid Medical (01789) surged more than 8% again, rising 7.92% as of the time of writing to HK$6.27, with a trading volume of HK$62.89 million.
AK MEDICAL (01789) rose by over 8%, and at the time of writing, it had increased by 7.92% to HK$6.27, with a turnover of HK$62.899 million.
On the news front, AK MEDICAL previously released its annual performance, with a total revenue of RMB 1.482 billion for the year, an increase of 10.1% year-on-year; the company's equity shareholders' share of the annual profit was RMB 339 million, an increase of 23.8% year-on-year. The significant increase in profits is mainly attributed to the growth in revenue and the increase in gross profit margin due to the improvement in overseas and digital orthopedic customized products and services. Among them, the sales revenue of orthopedic surgery Siasun Robot&Automation grew by over 200%.
GF SEC released a research report stating that the "AK+JRI" dual-brand synergy strategy actively provides overseas customers with 3D printed customized prostheses and orthopedic surgery Siasun Robot&Automation products and services. The company has already sold 3 Siasun Robot&Automation surgical units in the international market, with multiple orders in the process of being signed, demonstrating the growth potential of orthopedic surgery Siasun Robot&Automation and high-end brand products in the international market.
Related Articles

TCL ELECTRONICS (01070) establishes an Environment, Social, and Governance Committee.

HK FINANCE GP (01273) granted a new loan of 16 million Hong Kong dollars.

DAOHE GLOBAL (00915) released its annual performance. The profit attributable to shareholders was $77,000, a decrease of 97.10% compared to the previous year.
TCL ELECTRONICS (01070) establishes an Environment, Social, and Governance Committee.

HK FINANCE GP (01273) granted a new loan of 16 million Hong Kong dollars.

DAOHE GLOBAL (00915) released its annual performance. The profit attributable to shareholders was $77,000, a decrease of 97.10% compared to the previous year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


